Food and Drug Administration (FDA) approved a groundbreaking oral GLP-1 weight-loss medication the Wegovy pill from Novo Nordisk marking the first time a glucagon-like peptide-1 (GLP-1) receptor agonist for weight management can be taken as a daily tablet rather than by injection
Count on the percentage of spending on GLP-1 drugs to at least double over the next one to two years
Retatrutide is a "triple G" or GGG tri-agonist, meaning it engages three types of hormone receptorsGLP-1, GIP, and GCG
Lancet 398 , 21602172 (2021)
The topical application of 10% tea tree oil in dimethyl sulfoxide (DMSO) has significant inhibition in tumor growth of mice bearing subcutaneous melanoma tumors
Author contributions All authors above made substantial contributions to the conception or design of the work or the acquisition, analysis or interpretation of data for the work and drafting the work or revising it critically for important intellectual content and gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
